Devrekha Pharmaceuticals Private Limited
About Devrekha Pharmaceuticals Private Limited
Data last updated:
Devrekha Pharmaceuticals Private Limited is a private limited company based in Gangoh, Uttar Pradesh, India. It was incorporated on 07 July 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U47737UP2023PTC185258. Its GSTIN is 09AAKCD1469P1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Dharmveer Singh and Monika Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gangoh, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.8 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹56,521 (net margin 1.5%) and EBITDA of ₹68,491 (EBITDA margin 1.9%).
Company details
Contact details
Devrekha Pharmaceuticals Private Limited's registered office is in Gangoh, Uttar Pradesh.
- Registered AddressHouse No: – 142, Dubhar Kishanpur, Gangoh, Uttar Pradesh, India – 247341
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Devrekha Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Devrekha Pharmaceuticals Private Limited, buy the company report.
Financials of Devrekha Pharmaceuticals Private Limited
FY 2025 filings availableDevrekha Pharmaceuticals Private Limited reported revenue of ₹36.8 Lakh (up 191% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 191% in the latest year. EBITDA rose 114% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹68,491 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹56,521 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.9% | |
| Net Profit Margin | 1.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Devrekha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Devrekha Pharmaceuticals Private Limited
Devrekha Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmveer Singh | Director | 07 Jul 2023 | 3 Years 4 Months | Current |
| Monika Devi | Director | 07 Jul 2023 | 3 Years 4 Months | Current |
Peer comparison
Devrekha Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Moonford Pharmaceuticals Private Limited | ₹36.83 Lakh (FY 2024) | Haridwar, Uttarakhand, India | ||||
| Albro Pharmaceuticals Pvt Ltd | ₹36.8 Lakh (FY 2022) | -89.0% | Punjab, India | |||
| Devrekha Pharmaceuticals Private Limitedthis company | ₹36.8 Lakh (FY 2025) | ₹56,521 | 1.5% | 191.0% | Gangoh, Uttar Pradesh, India | |
| Svior Pharmaceuticals Private Limited | ₹36.76 Lakh (FY 2024) | -18.0% | Delhi, India |
To see the full peer comparison of Devrekha Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Devrekha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Devrekha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Devrekha Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCD1469P1ZX | Uttar Pradesh | Active | 23 Aug 2023 |
To see the full GST registrations and return filing status of Devrekha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Devrekha Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Dharmveer Singh was appointed as Director on 07 Jul 2023.
Frequently asked questions
Devrekha Pharmaceuticals is an active private limited company based in Gangoh, Uttar Pradesh, India. It was incorporated on 07 July 2023 (3+ years old) and is registered under CIN U47737UP2023PTC185258.
Devrekha Pharmaceuticals has 2 current directors:
- Dharmveer Singh - Director
- Monika Devi - Director
The latest financial statements of Devrekha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Devrekha Pharmaceuticals is 09AAKCD1469P1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Devrekha Pharmaceuticals is U47737UP2023PTC185258. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devrekha Pharmaceuticals was incorporated on 07 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Devrekha Pharmaceuticals by revenue are Moonford Pharmaceuticals Private Limited, Albro Pharmaceuticals Pvt Ltd, Svior Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dharmveer Singh was appointed as Director on 07 Jul 2023. Monika Devi was appointed as Director on 07 Jul 2023. Ramit Kumar was appointed as Individual Subscriber on 07 Jul 2023.
The registered office of Devrekha Pharmaceuticals is at House No: – 142, Dubhar Kishanpur, Gangoh, Uttar Pradesh, India – 247341.
Devrekha Pharmaceuticals can be reached at its registered office: House No: – 142, Dubhar Kishanpur, Gangoh, Uttar Pradesh, India – 247341.
Devrekha Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
